Evidence map›Paper›PMID 27468286›Full record

ArticleFrontiers in microbiology2016

Dynamic Immune Cell Recruitment After Murine Pulmonary Aspergillus fumigatus Infection under Different Immunosuppressive Regimens.

Natarajaswamy Kalleda, Jorge Amich, Berkan Arslan, Spoorthi Poreddy, Katharina Mattenheimer, Zeinab Mokhtari, Hermann Einsele, Matthias Brock, Katrin Gertrud Heinze, Andreas Beilhack

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Studies in mycology · 2021
    Review
  8. Review
  9. Article
  10. A transcriptional signature accurately identifies Aspergillus Infection across healthy and immunosuppressed states.Translational research : the journal of laboratory and clinical medicine · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Journal of immunology research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Natarajaswamy KalledaDepartment of Medicine II, Würzburg University HospitalWürzburg, Germany; Research Center for Infectious Diseases, Julius-Maximilians-University WürzburgWürzburg, Germany; Interdisciplinary Center for Clinical Science Research LaboratoryWuürzburg, Germany; Graduate School of Life Sciences WürzburgWürzburg, Germany.
Jorge AmichDepartment of Medicine II, Würzburg University HospitalWürzburg, Germany; Research Center for Infectious Diseases, Julius-Maximilians-University WürzburgWürzburg, Germany.
Berkan ArslanDepartment of Medicine II, Würzburg University Hospital Würzburg, Germany.
Spoorthi PoreddyMax Planck Institute for Chemical Ecology Jena, Germany.
Katharina MattenheimerDepartment of Medicine II, Würzburg University Hospital Würzburg, Germany.
Zeinab MokhtariDepartment of Medicine II, Würzburg University Hospital Würzburg, Germany.
Hermann EinseleDepartment of Medicine II, Würzburg University Hospital Würzburg, Germany.
Matthias BrockLeibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Friedrich Schiller University JenaJena, Germany; Institute for Microbiology, Friedrich Schiller University JenaJena, Germany; Fungal Genetics and Biology Group, University of Nottingham, School of Life SciencesNottingham, UK.
Katrin Gertrud HeinzeRudolf Virchow Center, Julius-Maximilians-University Würzburg Würzburg, Germany.
Andreas BeilhackDepartment of Medicine II, Würzburg University HospitalWürzburg, Germany; Research Center for Infectious Diseases, Julius-Maximilians-University WürzburgWürzburg, Germany; Interdisciplinary Center for Clinical Science Research LaboratoryWuürzburg, Germany; Graduate School of Life Sciences WürzburgWürzburg, Germany.
Universitätsklinikum Würzburg · DEUniversity of Würzburg · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEMax Planck Institute for Chemical Ecology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humans are continuously exposed to airborne spores of the saprophytic fungus Aspergillus fumigatus. However, in healthy individuals pulmonary host defense mechanisms efficiently eliminate the fungus. In contrast, A. fumigatus causes devastating infections in immunocompromised patients. Host immune responses against A. fumigatus lung infections in immunocompromised conditions have remained largely elusive. Given the dynamic changes in immune cell subsets within tissues upon immunosuppressive therapy, we dissected the spatiotemporal pulmonary immune response after A. fumigatus infection to reveal basic immunological events that fail to effectively control invasive fungal disease. In different immunocompromised murine models, myeloid, notably neutrophils, and macrophages, but not lymphoid cells were strongly recruited to the lungs upon infection. Other myeloid cells, particularly dendritic cells and monocytes, were only recruited to lungs of corticosteroid treated mice, which developed a strong pulmonary inflammation after infection. Lymphoid cells, particularly CD4(+) or CD8(+) T-cells and NK cells were highly reduced upon immunosuppression and not recruited after A. fumigatus infection. Moreover, adoptive CD11b(+) myeloid cell transfer rescued cyclophosphamide immunosuppressed mice from lethal A. fumigatus infection but not cortisone and cyclophosphamide immunosuppressed mice. Our findings illustrate that CD11b(+) myeloid cells are critical for anti-A. fumigatus defense under cyclophosphamide immunosuppressed conditions.

Indexed as

Aspergillus fumigatusCD11b+ myeloid cellscorticosteroids and cyclophosphamideimmune cell recruitment

Identifiers

PMID27468286
PMCPMC4942482
OpenAlexW2469213519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.